7 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Inhibitors #AntiPlatelet ... #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions #Pharmacology ... #Cardiology
Loop diuretic PO --> IV conversions 

Furosemide 40 mg PO = Furosemide 20 mg IV =
20 mg PO/IV = Bumetanide ... 1 mg PO/IV #Pharmacology ... #Cardiology #Loop ... Dose #Conversion #Table ... #Bumex #Lasix #Bumetanide
Loop diuretic conversion - Equivalent Doses
Furosemide (Lasix) 40 mg PO = Furosemide 20 mg IV =
20 mg PO/IV = Bumetanide ... 1 mg PO/IV #Pharmacology ... #Cardiology #Loop ... Doses #Conversion #Table ... #Bumex #Lasix #Bumetanide
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy #Table ... #Overview
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - Pharmacology ... Rate control of a-fib ... Rate control of a-fib ... Beta #Blockers #Pharmacology ... #Receptors #cardiology
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... anticoagulation in a-fib ... Medications #Summary #Table ... #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
to hypertension Antiplatelets ... supplementals #herbal #pharmacology ... #DDI #table #cardiology